Intellectual Property
Asia-Pacific Guide 2025 : Australia
Band 4
Email address
[email protected]Contact number
+61 3 9258 3555About
Provided by Maddocks
Organisations spend time and money creating valuable intellectual property (IP). How do you then properly use that IP and protect it?
The Maddocks IP team comprises partners and lawyers with extensive specialist advisory and dispute capabilities.
Their experience ranges from patent advice and commercialisation to copyright and design advice and transactions. We also advise on trademark registration, portfolio management and business name and domain name registration, as well as marketing and advertising advice.
Should an IP dispute arise, we provide dispute resolution and litigation services. We have successfully represented clients on patent infringement and invalidity, passing off and breaches of Australian Consumer Law, and the infringement of trademarks, copyright and design rights.
Our patent litigation team has represented clients in significant disputes in the Federal Court, Full Court and High Court of Australia, spanning a range of technologies from pharmaceuticals and telecommunications.
We have recently acted in particular cases relating to blockbuster drug patents, including extended release formulations, second medical use patents and dosage regimens.
Maddocks is a proud Finalist of the IP Transactions and Advisory Firm of the Year at the Managing IP Awards, 2023.
Chambers Review
Maddocks boasts a notable practice with capabilities to handle a wide range of IP matters. It provides particular strength in patents, acting on licensing agreements and commercialisation as well as substantial litigation proceedings in the pharmaceutical, medical technology and chemical engineering industries. It also offers expertise on an array of trade mark-related legal services, including portfolio management, licensing, brand acquisitions and oppositions. Additionally, Maddocks is active on copyright enforcement matters.
Work Highlights
- Maddocks acted for Cipla in proceedings to revoke two of BMS and Pfizer’s patents relating to apixaban, the anticoagulant drug marketed as ELIQUIS.
Notable Practitioners
Ben Miller has a well-established reputation in the patent litigation space, where he frequently acts for big-name clients in the pharmaceutical and biotechnological sectors.
"Ben'sclear, crisp and comprehensive advice is helpful especially for decision makers."
"Ben makes us feel that we are the biggest client."